Daptomycin is a lipopeptide antibiotic that binds to and depolarizes bacterial cell membranes. Its antibacterial activity requires calcium and correlates with the content of phosphatidylglycerol in the target membrane. Daptomycin has been shown to form oligomers on liposome membranes.
Introduction
Daptomycin is a cyclic lipopeptide that consists of 13 amino acid residues, including one kynurenine residue and several other non-standard amino acids, and a decanoyl fatty acyl residue attached to the exocyclic N-terminal tryptophan residue (see Figure 1 ). It is produced by the soil bacterium Streptomyces roseosporus. Daptomycin is used in the treatment of infections by Grampositive bacteria such as enterococci and staphylococci, including strains that are resistant to penicillin, methicillin and vancomycin [1, 2] . Daptomycin binds and depolarizes the bacterial cytoplasmic membrane [3] . Its activity requires calcium and correlates with the target membrane's content of phosphatidylglycerol (PG); increased conversion of PG to lysyl-PG confers partial resistance to bacterial cells [4, 5] .
Using FRET between the kynurenine residue of unlabeled daptomycin and a fluorescently labeled derivative of daptomycin, we have shown before that daptomycin forms oligomers on liposome membranes [6] . Oligomerization occurs under conditions that resemble those required for its antibacterial activity, suggesting that the oligomer is involved in the bactericidal effect.
In this study, we have used excimer fluorescence in order to further characterize the membraneassociated daptomycin oligomer. An excimer, or excited dimer, is a complex that forms from one fluorophore molecule that is in the excited state and another one in the ground state [7] . Since this requires direct contact between two fluorophore molecules, the detection of excimer fluorescence imposes a more stringent constraint on the distance of the interaction than that implied by the observation of FRET.
The fluorophore most widely used to study excimer fluorescence is pyrene, whose excimer and monomer spectra are well separated. However, when pyrene was incorporated into daptomycin, we observed that most pyrene fluorescence was lost due to energy transfer to kynurenine. We therefore chose to incorporate perylene, which emits at longer wavelengths [8] and therefore should not engage in FRET to kynurenine.
A prior study has shown that substitutions of the N-terminal decanoyl moiety of daptomycin are quite compatible with its antibacterial activity, as long as the introduced substituents retain an overall hydrophobic character [9] . Pyrene and perylene are very hydrophobic molecules, and accordingly they were introduced into daptomycin by replacing the decanoyl chain with pyrenebutanoic acid and perylene-butanoic acid, respectively. The derivatives retained antibacterial activity, albeit at a slightly reduced level in the case of perylene-daptomycin. Nevertheless, oligomer formation of perylene-daptomycin was clearly evident through excimer fluorescence, under conditions that mirrored those use in the previous FRET experiments. This result indicates that the fatty acyl residues of adjacent subunits of the membrane-associated daptomycin oligomer are within immediate reach of one another.
In a lipid bicelle system, the excimer fluorescence could be titrated with phosphatidylglycerol.
Conversion of monomer fluorescence to excimer fluorescence approached saturation at an equimolar ratio of phosphatidylglycerol to daptomycin. Therefore, a single molecule of phosphatidylglycerol is sufficient to convert daptomycin to a conformation that is competent for oligomerization.
Our study provides significant additional insight into the process of daptomycin oligomerization.
At the same time, it demonstrates that perylene excimer fluorescence is useful as a probe in the experimental study of biochemical systems.
Materials and Methods
Synthesis of perylene-daptomycin. To a suspension of deacylated daptomycin bearing a Boc protecting group on the ornithine residue (120 mg, 0.077 mmol; generously provided by Jared Silverman of Cubist Inc.) in dry dimethylformamide (0.5 mL) was added 4-(3-perylenyl)butanoic acid succinimidyl ester (see supporting information; 0.035g, 0.08 mmol). The mixture was stirred for 24 h and then concentrated by high vacuum rotary evaporation. The residue was dissolved in water and lyophilized. The lyophilized powder was dissolved in an ice cold solution of trifluoroacetic acid (TFA) containing 2% thioanisole, and the resulting solution was stirred for 15 minutes at 0 ºC (ice bath). The mixture was concentrated using a high vacuum rotary evaporator, keeping the heating bath below 40 ºC. The residue was dissolved in water and lyophilized. The resulting crude powder was purified by semi-preparative reversed phase HPLC employing a linear gradient starting with 95% water (0.1% TFA)-5% acetonitrile to 100 % acetonitrile over 50 minutes (t r =34 min). Fractions containing the desired product were pooled and concentrated using a high vacuum rotary evaporator keeping the heating bath below 40 ºC. The resulting residue was lyophilized to give 0.047 g (34% yield) of perylene-daptomycin as a yellow powder.
-ESIMS: 1784.76 (M-H) -1 ( Figure S1 ). The analytical reversed-phase HPLC chromatogram of the purified material, using a linear gradient starting with 95% water (0.1% TFA)-5% acetonitrile to 100 % acetonitrile over 50 minutes is shown in Figure S2 .
Synthesis of pyrene-daptomycin. This compound was prepared using the same procedure as that described above for perylene-daptomycin using 0.0081 g (0.021 mmol) 1-pyrenebutanoic acid succinimidyl ester and 0.030 g (019 mmol) deacylated daptomycin bearing a Boc protecting group on the ornithine residue. The crude product was purified by HPLC as described above for perylene-daptomycin (t r =28 min). Fractions containing the desired product were pooled and concentrated and the resulting residue lyophilized to give 17 mg (51% yield) of pyrene-daptomycin as a white powder.
-ESIMS: 1734.75 (M-H) -1 ( Figure S3 ). The analytical reversedphase HPLC chromatogram of the purified material using the conditions described above for perylene-daptomycin is shown in Figure S4 .
Antibacterial activity test for pyrene-and perylene-daptomycin. The two labeled derivatives as
well as native daptomycin were tested for antibacterial activity by broth dilution. LB broth was supplemented with calcium (5 mM), and the daptomycin derivative in question was added at concentrations of 10, 5, 3, 2, 1.5, and 1 μg/ml. Each tube was inoculated with Bacillus subtilis ATCC 1046 and incubated overnight at 37 ºC. Growth inhibition was evaluated visually by turbidity. Growth controls without antibiotic were prepared for comparison. were corrected for wavelength-dependent instrument response using a quinine sulfate standard and a tabulated normalized quinine spectrum listed in [7] .
Preparation of large unilamellar vesicles (LUV
Fluorescence lifetime measurements were performed on a FluoTime 100 Lifetime spectrometer (PicoQuant, Berlin, Germany), using diode laser light sources emitting at 370 nm and at 440 nm for pyrene and perylene, respectively. The emission was isolated using 460±10 nm or 560±10 nm Deconvolution of perylene excimer and monomer spectra. Perylene fluorescence decays were measured at 560±10 nm on DMPC/DMPG membranes, both with pure perylene-daptomycin and with a mixture of perylene-daptomycin and a fivefold excess of unlabeled daptomycin. The decays were fitted to a two-exponential model. The fractional emission intensities of the monomer and the excimer at 560 nm were obtained from these data according to
From the spectrum of perylene-daptomycin only, P, and the spectrum of the mixture of perylene-daptomycin with unlabeled daptomycin, U, the pure excimer spectrum, E, was calculated as where I P, 560 and I U, 560 denote the intensity of P and U at 560 nm, respectively. The pure monomer spectrum M was obtained analogously. After normalizing E and M to the same quantity of molecules, the quantum yield of the excimer, relative to that of the monomer, was calculated from the ratio of the areas of the two normalized spectra.
Titration of perylene excimer fluorescence with phosphatidylglycerol. To a solution of 100 μM perylene-daptomycin, 1 mM Ca ++ and 20 mM DHPC in HBS, a mixture of DMPC and DMPG (molar ratio, 4:1) was added in a stepwise fashion. After each addition, the mixture was incubated for 2 minutes before acquisition of the perylene emission spectrum. Repeated scans showed that this short incubation sufficed to reach equilibrium. From each spectrum, the ratio of the emission intensities at 521nm and 480 nm was calculated, and the increment was plotted as a function of the molar ratio of DMPG to perylene-daptomycin.
Results
Synthesis and purification of pyrene-and perylene-daptomcyin. The synthetic procedure, as well as mass spectrometry and chromatography data on the product are given in the supplementary information file. The structures of pyrene-and perylene-daptomycin are shown in Figure 1 .
Antibacterial activity of pyrene-and perylene-daptomycin. The antibacterial activity of pyreneand perylene-daptomycin against Bacillus subtilis strain ATCC 1046 was determined by broth dilution, using native daptomycin as a reference. The minimum inhibitory concentration of perylene-daptomycin was 3 μg/ml, compared to 1 μg/ml for native daptomycin and pyrenedaptomycin. Therefore, the specific activity of perylene-daptomycin is approximately 3 times lower than that of native daptomycin and of pyrene-daptomycin.
Fluorescence of pyrene-daptomycin. Figure 2 shows the emission spectra of pyrene-daptomycin in solution and on liposomes consisting of phosphatidylcholine (PC) and phosphatidylglycerol (PG). Pyrene monomer fluorescence, which is apparent in the small peaks to both sides of 380 nm, is very low in both samples. There is a broad peak around 460 nm that greatly increases after incubation with the liposomes, on which daptomycin has been shown to form oligomers.
While oligomer formation should be accompanied by excimer formation, the latter should be accompanied by a decrease of monomer emission, which however is low to begin with and does not decrease any further. Furthermore, the peak at 460 nm has an average excited state lifetime of approximately 3.5 nanoseconds (data not shown), whereas the typical lifetimes of pyrene excimers are much longer. On the other hand, the observed lifetime is very similar to that found previously for the kynurenine residue of daptomycin [6] .
The monomer emission spectrum of pyrene significantly overlaps the absorption spectrum of the kynurenine residue, which should cause fluorescence energy transfer from excited pyrene to kynurenine. The increase in the sensitized kynurenine emission upon membrane binding mirrors that of directly excited kynurenine fluorescence reported earlier [11] .
In sum, because of spectral overlap between pyrene emission and kynurenine absorption, pyrenedaptomycin does not produce experimentally useful excimer fluorescence.
Observation of perylene-daptomycin excimer fluorescence. The emission spectrum of perylenedaptomycin in solution resembles that of monomeric, free perylene in hexane [8] , with three distinct peaks between 450 and 520 nm ( Figure 3A) . A similar spectrum is obtained when perylene-daptomycin is incubated with DMPC membranes ( Figure 3B ). In contrast, on membranes composed of DMPC and DMPG, as well as on bacterial cells, the shape of the spectrum changes significantly ( Figure 3C , D). The two leftmost peaks are greatly decreased, and a new, broad peak emerges that overlaps the monomer fluorescence. While the new peak is centered around 525 nm and therefore is blue-shifted relative to the excimer of free perylene [8] , its shape nevertheless is suggestive of excimer fluorescence. This interpretation is corroborated by time-resolved fluorescence measurements. Figure 4 shows the fluorescence decays measured at 560 nm of perylene-daptomycin on PC liposomes (A) and on PC/PG liposomes (B). Both decays can be fitted quite well with a two-exponential model (see fit parameter values in the figure), and the lifetime parameters obtained from these fits are similar to those of perylene monomers and excimers reported earlier [8] . Note that the pre-exponentials are different between the two membranes, which reflects a higher prevalence of excimers on the PC/PG membranes.
Also, the fitted fluorescence lifetime of the putative excimer component is shorter in PC than in PC/PG membranes.
Excimer fluorescence only occurs when a monomer in the excited state binds directly to a another monomer that is in the ground state. It should therefore be greatly facilitated by the formation of stable oligomers, since within these the perylene moieties should remain close to one another throughout. On the other hand, a mixture of perylene-daptomycin with an excess of unlabeled daptomycin should produce hybrid oligomers, within which the perylene-labeled molecules should become separated from one another by intervening unlabeled molecules. This should lead to increased monomer fluorescence and decreased excimer fluorescence. Figure 5 shows that this is indeed the case. It also shows that, on PC membranes, the ratio of excimer fluorescence to monomer fluorescence is not affected by the addition of unlabeled daptomycin. This is in line with the assumption that stable oligomers do not form on these membranes, and that excimer fluorescence arises by diffusional collision of individual perylene-daptomycin molecules only.
Very similar spectra and fluorescence lifetimes were obtained on liposomes consisting of POPE, DOPG and TOCL, which are considered models of the cytoplasmic membranes of bacteria [12, 13] . This is in line with prior observations [6] .
Quantitative evaluation of excimer fluorescence. By combining lifetime data with steady state spectra, we can obtain an approximation of the spectrum of the excimer, as well as an estimate of its quantum yield relative to that of the monomer. The calculation, which is detailed in the Methods section, yields the monomer and excimer spectra shown in Figure 6 . The quantum yield of the excimer, relative to that of the monomer, is 0.35.
On PC/PG membranes, the observed excimer emission corresponds to > 90% of all excitation events. If we neglect excimer emission due to collisional encounters of the few remaining monomers, we can infer that more than 90% of all daptomycin molecules are now located in oligomers. Considering that some excited perylene molecules will emit monomer fluorescence even when placed in the vicinity of other perylene molecules, the extent of oligomer formation may well be even higher.
At an oligomerization efficiency of 90%, the ratio of emission at 521 nm to that at 482 nm is 1.35
( Figure 3C ). This ratio is 0.33 for PC liposomes (Fig. 3B) , on which perylene-daptomycin emits mostly as a monomer. On bacterial cells (Fig. 3D) , it is 1.16, which shows that most of the cell-bound perylene-daptomycin have become incorporated into oligomers. Therefore, on suitable membranes, oligomerization of daptomycin approaches or reaches completion.
Titration of excimer fluorescence with phosphatidylglycerol.
In previous studies [6, 11, 14] , phosphatidylglycerol was used in considerable molar excess over daptomycin, and therefore these experiments did not provide information on the stoichiometry of the interaction of daptomycin with PG. To examine this question, we used a mixture of DMPC and DMPG with an excess of dihexanoyl-PC. Mixtures of the latter with lipids of typical acyl chain length yield lipid bicelles, which are small, disk-like lipid aggregates that are suitable as membrane mimetics [15] .
The advantage of bicelles over liposomes is twofold. Firstly, suspensions of bicelles are much less turbid. This allows measurements at higher concentrations of daptomycin and PG, which will help to drive the reaction between the two toward completion. Secondly, in a bicelle, both monolayers will be exposed to daptomycin. In contrast, with liposomes, only the outer monolayer may be accessible. Previous observation of membrane fusion induced by daptomycin in model liposomes [14] suggests that the membrane continuity may be disrupted, and both monolayers may be accessible to daptomycin in this system also. On the other hand, membrane fusion did not go to completion. In addition, no morphological changes to the cell membranes of daptomycintreated bacteria were observed by electron microscopy [16] , suggesting that the inner monolayer me not or only incompletely accessible to daptomycin. Use of bicelles avoids this uncertainty. Figure 7 shows the titration of 100 μM perylene-daptomycin, in 20 mM dihexanoyl-PC and 1 mM calcium, with a mixture of dimyristoyl-PC and dimyristoyl-PG. Excimer formation is monitored as the ratio of fluorescence intensities at wavelengths 521 nm and 482 nm. It can be seen that the extent of excimer formation, and thus oligomerization, approaches saturation after addition of a stoichiometric amount of phosphatidylglycerol.
Discussion
In this study, we synthesized pyrene-daptomycin and perylene-daptomcyin and used the latter to characterize the oligomerization of daptomycin on membranes. The perylene moiety was introduced into daptomycin by substituting it for the normal decanoyl chain. Considering the substantial bulk that is added to the molecule by this modification, the fact that the antimicrobial activity is reduced no more than threefold is quite remarkable, as is the observation that the introduction of pyrene caused no measurable decrease in activity at all. These observations are, however, in line with a previous study on a variety of acyl analogues, which revealed only minor changes to the antibacterial activity, as long as the overall hydrophobic character of the acyl chain was preserved [9] . While the spectral overlap between pyrene and kynurenine prevented the observation of pyrene excimer fluorescence, excimers could be observed and used to characterize the oligomerization of daptomycin.
The perylene excimer fluorescence indicated the formation of daptomycin oligomers on both liposomes and bacterial cells. In liposomes, oligomerization correlates with the presence of phosphatidylglycerol. These findings are entirely consistent with those of a previous study that used fluorescence energy transfer [6] . Beyond this confirmation, the use of perylene-daptomcyin provides significant additional insights that could not be inferred from previous experiments.
The first novel observation is the formation of daptomycin oligomers on live bacterial cells.
Secondly, using perylene-daptomcyin, the extent of oligomerization could be measured. This extent exceeds 90% on model membranes that contain 50% DMPG, and it is only slightly lower on bacterial membranes. This high extent of oligomerization supports the notion that it is the oligomer that causes the bactericidal effect.
Thirdly, the formation of perylene excimers shows that, in the oligomer, the N-terminal acyl chains interact directly with one another. Direct interaction of the daptomycin peptide moieties within the oligomer was previously inferred from the self-quenching of NBD-labels that had been attached to their ornithine residues [6] . Taken together, these two points of mutual interaction suggest that neighboring oligomer subunits are aligned in a parallel fashion, or form an acute angle with one another.
The fourth novel finding reported here is that daptomycin oligomerization is driven by a stoichiometric interaction with phosphatidylglycerol. This result suggests that PG interacts with daptomycin directly and specifically, rather than indirectly through influencing bulk properties of the membrane such as charge or lateral phase segregation. Enhanced conversion of PG to lysyl-PG by bacterial cells has been reported as a mechanism of partial resistance to daptomycin [4, 5] , which supports the notion that PG-mediated oligomerization is essential for the activity of daptomycin.
In summary, the current study provides significant new insights into the interaction of daptomycin with itself and with membrane lipids. At the same time, this study is the first one to use perylene excimer fluorescence for the characterization of peptide or protein oligomerization.
The results provided here illustrate that perylene should be a valuable tool wherever the occurrence of intrinsic chromophores or fluorophores precludes the use of pyrene-labeled probes. Figure 1 : Structure of daptomycin, and of the substituents pyrene-and perylene-butanoic acid that were substituted for the decanoyl residue of the native compound in this study. Figure 3B and 3C, respectively.
Legends to Figures
Excitation was with a 440 nm diode laser. Emission was measured using a 560±10 nm bandpass filter. The decays were fitted to a two-exponential model. Pre-exponentials (α) and lifetimes (τ) of the fitted components, as well as the residuals and χ 2 of the fits are given. 
